GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tci Gene Inc (ROCO:6879) » Definitions » Other Net Income (Loss)

Tci Gene (ROCO:6879) Other Net Income (Loss) : NT$0.0 Mil (TTM As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Tci Gene Other Net Income (Loss)?

Tci Gene's Other Net Income (Loss) for the six months ended in Dec. 2023 was NT$0.0 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Dec. 2023 was NT$0.0 Mil.

Tci Gene's quarterly Other Net Income (Loss) stayed the same from Dec. 2022 (NT$0.0 Mil) to Jun. 2023 (NT$0.0 Mil) but then increased from Jun. 2023 (NT$0.0 Mil) to Dec. 2023 (NT$0.0 Mil).

Tci Gene's annual Other Net Income (Loss) stayed the same from Dec. 2021 (NT$-0.0 Mil) to Dec. 2022 (NT$-0.0 Mil) but then increased from Dec. 2022 (NT$-0.0 Mil) to Dec. 2023 (NT$0.0 Mil).

Tci Gene Other Net Income (Loss) Historical Data

The historical data trend for Tci Gene's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tci Gene Other Net Income (Loss) Chart

Tci Gene Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Other Net Income (Loss)
- - - - -

Tci Gene Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Other Net Income (Loss) Get a 7-Day Free Trial Premium Member Only - - - - -

Tci Gene Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tci Gene Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Tci Gene's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Tci Gene (ROCO:6879) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tci Gene Inc (ROCO:6879) » Definitions » Other Net Income (Loss)
Comparable Companies
ROCO:6580 ROCO:6564 ROCO:6846 TPE:3164 ROCO:4724 ROCO:6892 TPE:4133 ROCO:4171 TPE:1733 ROCO:7427 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
N/A
Address
No. 185-1, Gangqian Rd, 10th FLoor, Neihu District, Taipei, TWN
Website
https://www.genext.me
Tci Gene Inc provides precision preventive medicines in Taiwan. It is the first to introduce the concept of precision preventive medicine with Predict prediction, Prevent prevention, and Personal Treatment personalized health management measures.

Tci Gene (ROCO:6879) Headlines

No Headlines